Biotech · Public company · Austin, TX, US
Savara Inc
Ticker SVRA · SEC CIK 0001160308
Track this companyFree. Adds Savara Inc to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline8
- MolgramostimPhase 3 · Autoimmune Pulmonary Alveolar ProteinosisClinicalTrials.gov · fetched Nov 12, 2026
- Molgramostim Open-labelPhase 3 · Autoimmune Pulmonary Alveolar ProteinosisClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin inhalation powderPhase 3 · MRSAClinicalTrials.gov · fetched Nov 12, 2026
- Molgramostim nebulizer solutionPhase 2 · Mycobacterium Infections, NontuberculousClinicalTrials.gov · fetched Nov 12, 2026
- PARI eFlow nebulizer systemPhase 2 · Autoimmune Pulmonary Alveolar ProteinosisClinicalTrials.gov · fetched Nov 12, 2026
- PARI eFlow nebulizer systemPhase 2 · Mycobacterium Infections, NontuberculousClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin hydrochloride inhalation powderPhase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Molgramostim nebulizer solutionAutoimmune Pulmonary Alveolar ProteinosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)PHASE3 · ACTIVE_NOT_RECRUITING · started May 19, 2021ClinicalTrials.gov NCT04544293 · fetched Nov 12, 2026
- Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial InfectionPHASE2 · TERMINATED · started Jun 20, 2019ClinicalTrials.gov NCT03597347 · fetched Nov 12, 2026
- AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic FibrosisPHASE3 · COMPLETED · started Sep 20, 2017ClinicalTrials.gov NCT03181932 · fetched Nov 12, 2026
- Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar ProteinosisPHASE2 · COMPLETED · started Mar 21, 2016ClinicalTrials.gov NCT02702180 · fetched Nov 12, 2026
- Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis PatientsPHASE2 · COMPLETED · started Mar 1, 2013ClinicalTrials.gov NCT01746095 · fetched Nov 12, 2026
- Molgramostim Nebulizer Solution Expanded Access Program ProtocolAVAILABLEClinicalTrials.gov NCT06546098 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 13, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 30, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 29, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 2, 2025 · fetched Nov 12, 2026